Optimization and In vivo Pharmacokinetic Study of a Novel Controlled Release Venlafaxine Hydrochloride Three-Layer Tablet
- 8 June 2010
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 11 (3) , 1026-1037
Abstract
Several matrix tablet formulations (hydrophilic-based, wax-based, and three-layer tablets) were designed for controlling the release of the highly water soluble drug, venlafaxine hydrochloride (VenHCl) for once-daily administration. The three-layer tablets consist of non-swellable, compritol-based middle layers containing the drug to which hydrophilic top and bottom barrier layers were applied. A 23 full-factorial design was employed for optimization and to explore the effect of different variables on the release rate of the drug from the three-layer tablets. The optimized levels of each independent variable were based on the criterion of desirability. The calculated values of f 1 and f 2 were 4.131 and 79.356, respectively; indicating that the release profile of the optimized PEO layered tablet formulation is comparable to that of the target release model. The pharmacokinetic parameters of VenHCl from the optimized three-layer tablet was compared to the marketed extended release capsule as a reference in healthy human subjects using a randomized crossover design. In this study, the 90% confidence interval for AUC0–24 and AUC0−∞ are within (0.8–1.25), which satisfied the bioequivalence criteria. It could be concluded that a promising once-daily extended-release three-layer tablet of the highly water soluble drug, VenHCl, was successfully designed.Keywords
This publication has 24 references indexed in Scilit:
- Fabrication of Triple-Layer Matrix Tablets of Venlafaxine Hydrochloride Using Xanthan GumAAPS PharmSciTech, 2009
- Formulation Study and Evaluation of Matrix and Three-layer Tablet Sustained Drug Delivery Systems Based on Carbopols with Isosorbite MononitrateAAPS PharmSciTech, 2008
- Variables Influencing Drug Release from Layered Matrix System Comprising Hydroxypropyl MethylcelluloseAAPS PharmSciTech, 2008
- Optimization Studies on Design and Evaluation of Orodispersible Pediatric Formulation of IndomethacinAAPS PharmSciTech, 2008
- In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tabletsInternational Journal of Pharmaceutics, 2006
- A flexible technology for modified release of drugs: multi layered tabletsJournal of Controlled Release, 2004
- A flexible technology for modified release of drugs: multi layered tabletsJournal of Controlled Release, 2004
- Interpretation of Percent Dissolved-Time Plots Derived from In Vitro Testing of Conventional Tablets and CapsulesJournal of Pharmaceutical Sciences, 1969
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963
- Rate of Release of Medicaments from Ointment Bases Containing Drugs in SuspensionJournal of Pharmaceutical Sciences, 1961